Abbott Laboratories ranks slightly below the peer group median, with strong valuation and stability offset by weak profitability. The market setup has weakened, with clear trend damage and relative performance under pressure. Price behavior is partially reflecting the structural picture, with a moderate gap remaining.
Peer-relative scores, weakest to strongest
Abbott Laboratories develops and markets medical devices, diagnostics, and nutrition products. The company operates globally across healthcare segments.
The market prices Abbott as a defensive name with limited growth leverage, placing it below peer levels. Even with revenue growth of 7.8%—a figure above the peer median—the company’s overall momentum is limited by an EPS guidance of $5.38–$5.58, diluted by $0.20 from recent acquisitions, which shows that inorganic expansion has not resulted in growth comparable to more aggressive competitors. Abbott’s medical device segments perform well, but its total growth is lower than innovation-driven life science peers, supporting the market’s defensive assessment. As a result, the market assigns Abbott a valuation below peers that deliver higher growth rates and scale effects, reflecting its perceived lower growth potential. Sustained acceleration of organic growth to peer levels would be required to change this assessment and close the discount.
Break down ABT's position across all dimensions with the full interactive tool.
This analysis is rule-based and descriptive. Peer-relative scores are derived from functional peer group comparisons using publicly available financial data. Scores reflect structural positioning only and do not constitute investment advice, a buy or sell recommendation, or a forecast of future performance. AssetNext peer scores are recalculated periodically as new data becomes available.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.